State of Wisconsin Investment Board’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-242,794
Closed -$414K 2366
2025
Q1
$414K Buy
242,794
+209,105
+621% +$785K ﹤0.01% 1845
2024
Q4
$170K Sell
33,689
-41,778
-55% -$207K ﹤0.01% 2151
2024
Q3
$411K Buy
+75,467
New +$498K ﹤0.01% 1950
2024
Q2
Sell
-16,700
Closed -$51.9K 2336
2024
Q1
$51.9K Buy
+16,700
New +$56.2K ﹤0.01% 2159
2023
Q1
Sell
-49,706
Closed -$105K 2558
2022
Q4
$105K Sell
49,706
-3,545
-7% -$10.8K ﹤0.01% 2346
2022
Q3
$174K Sell
53,251
-3,115
-6% -$11.9K ﹤0.01% 2432
2022
Q2
$181K Buy
56,366
+13,666
+32% +$76K ﹤0.01% 2521
2022
Q1
$301K Buy
+42,700
New +$249K ﹤0.01% 2096

Other funds holding HUMA

State of Wisconsin Investment Board's HUMA Position: Q2 2025 in Review

State of Wisconsin Investment Board sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 242,794 shares — an estimated $414K sold.

State of Wisconsin Investment Board first reported a position in HUMA in Q1 2022 and held it in 8 quarters. The position peaked at $414K in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • State of Wisconsin Investment Board reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 242,794 Humacyte shares in Q2 2025, an estimated $414K.
  • State of Wisconsin Investment Board first reported a position in Humacyte in Q1 2022 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Humacyte position peaked at $414K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2025, filed 14 Aug 2025.